These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

294 related items for PubMed ID: 11380911

  • 1. Re-treatment for immune globulin-resistant Kawasaki disease: a comparative study of additional immune globulin and steroid pulse therapy.
    Hashino K, Ishii M, Iemura M, Akagi T, Kato H.
    Pediatr Int; 2001 Jun; 43(3):211-7. PubMed ID: 11380911
    [Abstract] [Full Text] [Related]

  • 2. Effects of steroid pulse therapy on immunoglobulin-resistant Kawasaki disease.
    Furukawa T, Kishiro M, Akimoto K, Nagata S, Shimizu T, Yamashiro Y.
    Arch Dis Child; 2008 Feb; 93(2):142-6. PubMed ID: 17962370
    [Abstract] [Full Text] [Related]

  • 3. [Steroid pulse therapy].
    Miura M.
    Nihon Rinsho; 2014 Sep; 72(9):1631-5. PubMed ID: 25518414
    [Abstract] [Full Text] [Related]

  • 4. Efficacy and safety of intravenous immunoglobulin plus prednisolone therapy in patients with Kawasaki disease (Post RAISE): a multicentre, prospective cohort study.
    Miyata K, Kaneko T, Morikawa Y, Sakakibara H, Matsushima T, Misawa M, Takahashi T, Nakazawa M, Tamame T, Tsuchihashi T, Yamashita Y, Obonai T, Chiga M, Hori N, Komiyama O, Yamagishi H, Miura M, Post RAISE group.
    Lancet Child Adolesc Health; 2018 Dec; 2(12):855-862. PubMed ID: 30337183
    [Abstract] [Full Text] [Related]

  • 5. The strategy of immune globulin resistant Kawasaki disease: a comparative study of additional immune globulin and steroid pulse therapy.
    Ogata S, Bando Y, Kimura S, Ando H, Nakahata Y, Ogihara Y, Kaneko T, Minoura K, Kaida M, Yokota Y, Furukawa S, Ishii M.
    J Cardiol; 2009 Feb; 53(1):15-9. PubMed ID: 19167633
    [Abstract] [Full Text] [Related]

  • 6. Randomized trial of pulsed corticosteroid therapy for primary treatment of Kawasaki disease.
    Newburger JW, Sleeper LA, McCrindle BW, Minich LL, Gersony W, Vetter VL, Atz AM, Li JS, Takahashi M, Baker AL, Colan SD, Mitchell PD, Klein GL, Sundel RP, Pediatric Heart Network Investigators.
    N Engl J Med; 2007 Feb 15; 356(7):663-75. PubMed ID: 17301297
    [Abstract] [Full Text] [Related]

  • 7. High regression rate of coronary aneurysms developed in patients with immune globulin-resistant Kawasaki disease treated with steroid pulse therapy.
    Adachi S, Sakaguchi H, Kuwahara T, Uchida Y, Fukao T, Kondo N.
    Tohoku J Exp Med; 2010 Apr 15; 220(4):285-90. PubMed ID: 20410679
    [Abstract] [Full Text] [Related]

  • 8. Pulse methylprednisolone therapy in the treatment of immune globulin-resistant Kawasaki disease: case report and review of the literature.
    Hung JJ, Chiu CH.
    Ann Trop Paediatr; 2004 Mar 15; 24(1):89-93. PubMed ID: 15005973
    [Abstract] [Full Text] [Related]

  • 9. Methylprednisolone pulse therapy for massive lymphadenopathy in a child with intravenous immunoglobulin-resistant Kawasaki disease.
    Chen HH, Liu PM, Bong CN, Wu YT, Yang KD, Wang CL.
    J Microbiol Immunol Infect; 2005 Apr 15; 38(2):149-52. PubMed ID: 15843862
    [Abstract] [Full Text] [Related]

  • 10. Methylprednisolone pulse and prednisolone for intensification of primary treatment in Kawasaki disease patients at high risk of treatment resistance: a multicenter prospective cohort study.
    Miura M, Miyata K, Kaneko T, Akahoshi S, Morikawa Y, Matsushima T, Sakakibara H, Kobayashi T, Nakamura T, Takahashi T, Nakazawa M, Shibata A, Yamagishi H.
    Eur J Pediatr; 2024 Oct 15; 183(10):4265-4274. PubMed ID: 39048743
    [Abstract] [Full Text] [Related]

  • 11. [Methylprednisolone pulse therapy in Kawasaki disease].
    Miura M, Matsuoka M, Kohno K, Ohki H, Yoshiba S.
    Nihon Rinsho; 2008 Feb 15; 66(2):338-42. PubMed ID: 18265457
    [Abstract] [Full Text] [Related]

  • 12. Steroid pulse therapy for children with intravenous immunoglobulin therapy-resistant Kawasaki disease: a prospective study.
    Teraguchi M, Ogino H, Yoshimura K, Taniuchi S, Kino M, Okazaki H, Kaneko K.
    Pediatr Cardiol; 2013 Apr 15; 34(4):959-63. PubMed ID: 23184018
    [Abstract] [Full Text] [Related]

  • 13. Methylprednisolone Pulse Therapy or Additional IVIG for Patients with IVIG-Resistant Kawasaki Disease.
    Wang Z, Chen F, Wang Y, Li W, Xie X, Liu P, Zhang X, Zhang L, Huang P.
    J Immunol Res; 2020 Apr 15; 2020():4175821. PubMed ID: 33299898
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Infliximab versus second intravenous immunoglobulin for treatment of resistant Kawasaki disease in the USA (KIDCARE): a randomised, multicentre comparative effectiveness trial.
    Burns JC, Roberts SC, Tremoulet AH, He F, Printz BF, Ashouri N, Jain SS, Michalik DE, Sharma K, Truong DT, Wood JB, Kim KK, Jain S, KIDCARE Multicenter Study Group.
    Lancet Child Adolesc Health; 2021 Dec 15; 5(12):852-861. PubMed ID: 34715057
    [Abstract] [Full Text] [Related]

  • 19. Role of glucocorticoids in Kawasaki disease.
    Miura M.
    Int J Rheum Dis; 2018 Jan 15; 21(1):70-75. PubMed ID: 29105310
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.